Our apologies, this section of our website is still under construction.
Please check back later for updates. Thank you.

Protocols

Procedure:Intra-articular Umbilical Cord Blood Stem Cell  Injection:  Hip Joint
Diagnosis:Osteoarthritis/Labral Tear/ etc.
Description:The right/left inguinal area was prepped and draped using standard  sterile  techniques. Using floroscopy guidance, the hip joint was clearly visualized. The anterior skin and subcutaneous region was injected with a mixture of 3 cc of  1% lidocaine & 2 cc of 0.5 % Marcaine  and a skin anesthesia was obtained. A 22 guage 6 inch spinal needle was inserted under floroscopic guidance into the hip joint and intra-capsular position was determined with infusion of a 1cc radio-opaque contrast solution. Thereafter, the MSC was obtained from the -80°C tissue bank freezer and rapidly brought to room temperature. The stem cells were handled with sterile techniques and expanded with 3cc of Normal Saline. The syringe with the Stem Cell solution was attached to the access portal. The solution was slowly injected over a 1 minute interval intra-articular hip joint with interval pause to assess for any adverse reaction. Then another 1cc of contrast dye was infused to confirm intra-capsular placement of the solution. No adverse reaction was noted. The spinal needle was then atraumatically removed and  a compressive bandage was then placed over the injection site.
Procedure:Intra-articular Umbilical Cord Blood Stem Cell Injection:  Knee Joint
Diagnosis:Osteoarthritis/Intra-articular soft tissue pathology
Description:The right/left knee was prepped and draped using standard sterile techniques. The anterior medial approach was used and the skin and subcutaneous region was injected with a mixture of 3 cc of  1% lidocaine & 2 cc of 0.5 % Marcaine  and a skin anesthesia was obtained. Thereafter, the UCBSC was obtained from the -80°C tissue bank freezer and rapidly brought to room temperature. The stem cells were handled with sterile techniques and expanded with 3cc of Normal Saline. The syringe with the Stem Cell solution was introduced into the medial compartment with a 22 gauge 1 1/2 inch needle. The solution was slowly injected over a one minute interval intra-articularly with interval pause to assess for any adverse reaction. No adverse reaction was noted. The spinal needle was then atraumatically removed and a compressive bandage was then placed over the injection site.
Procedure:Intra-articular Umbilical Cord Blood Stem Cell  Injection:  Glenohumeral Joint
Diagnosis:Osteoarthritis/Intra-articular soft tissue pathology
Description:The right/left shoulder anteriorly was prepped and draped using standard sterile  techniques.  The anterior approach was used and the skin and subcutaneous region lateral to the coracoid process was injected with a mixture of 3 cc of 1% lidocaine & 2 cc of 0.5 % Marcaine  and a skin anesthesia was obtained. Thereafter, the UCBSC were obtained from the -80°C tissue bank freezer and rapidly brought to room temperature. The stem cells were handled with sterile techniques and expanded with 3cc of Normal Saline. The syringe with the Stem Cell solution was introduced into the anterior Glenohumeral space with a 22 gauge 1 1/2 inch needle. The solution was slowly injected over a 1 minute interval intra-articularly with interval pause to assess for any adverse reaction. No adverse reaction was noted. The spinal needle was then atraumatically removed and a compressive bandage was then placed over the injection site.
Procedure:Intravenous Cord Blood Stem Cell Infusion
Diagnosis: 
Description:The antecubital area was prepped using standard sterile technique.  The antecubital venous access was obtained with atraumatic techniques and an intravenous catheter was placed. A 100cc solution of Normal Saline was started.  The UCBSC was obtained from the -80° tissue tissue bank freezer and rapidly brought to room temperature. The UCBSC were handled with sterile techniques and expanded with 3cc of Normal Saline. Using a midline access portal, the syringe with the Stem Cell solution was attached to the access portal. A 1cc volume of peripheral blood was withdrawn into the syringe and mixed with the Stem Cell solution. The solution was slowly injected over a 1 minute interval intravenously with interval pause to assess for any adverse reaction. No adverse reaction was noted. The IV tubing was then purged with the remainder of the 100cc bag of the NS. The IV was then atraumatically removed and  a compressive bandage was then placed over the infusion site.

Testimonials

Coming Soon.

Patient Conditions and Results

Results:Patient experienced a dramatic reduction in their pain level by 90% by the end of the 2nd month.
Results:Patient reported 90% pain relief by week 3.
Results:Patient had significant improvement reported on repeat MRI scan at 4 months.  Patient reported significant pain relief in months 2 and 3 following procedure.
Results:Patient 1 reported a significant decrease in pain in 1-2 weeks following procedure.  Patient 2 experience vast improvement in his fatigue level 2-4 weeks following procedure.
Results:Patient reported 90% pain relief by week 4.
Results:Patient experienced significant improvement gradually over a 2 week period following procedure.
Results:Patient 1 reported a significant improvement in 6-8 weeks following procedure.  Patient 2 reported a significant improvement after 2 weeks following procedure.
Results:Patient experienced a moderate improvement within days following procedure with improved energy and breathing.
Results:Patient experienced a mild improvement in their symptoms after 8 weeks following procedure.
Results:Patient reported a significant drop in pain after 1-2 weeks following procedure.
Results:Patients labs reported a significant improvement within 2 weeks following procedure.  Patients fasting sugars dropped from 160 to 80 per lab results.
0
Your Cart
Add to cart